Earl Jefferson, in Vallejo, CA - Case Manager/Care Coordinator

Earl Jefferson, is a Case Manager/care Coordinator based in Vallejo, California. Earl Jefferson is licensed to practice in * (Not Available) (license number ) and his current practice location is 508 Alabama St, Vallejo, California. He can be reached at his office (for appointments etc.) via phone at (510) 899-3704.

NPI number for Earl Jefferson is 1023337409 and his current mailing address is 3201 Curran Ave, Oakland, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1023337409.

Contact Information

	Earl Jefferson,
	508 Alabama St, Vallejo, CA 94590-4446
	(510) 899-3704
	Not Available

Healthcare Provider's Profile

Full Name	Earl Jefferson
Gender	Male
Speciality	Case Manager/care Coordinator
Location	508 Alabama St, Vallejo, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1023337409
Provider Enumeration Date: 05/24/2010
Last Update Date: 02/06/2023

Medical Identifiers

Medical identifiers for Earl Jefferson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023337409	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101Y00000X	Counselor	(* (Not Available))	Secondary
171M00000X	Case Manager/care Coordinator	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Earl Jefferson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Earl Jefferson, 3201 Curran Ave, Oakland, CA 94602-2825 Ph: (707) 208-2348	Earl Jefferson, 508 Alabama St, Vallejo, CA 94590-4446 Ph: (510) 899-3704

News Archive

New assay can identify rare cancerous cells within mixed populations

Rare cells can be identified within mixed cell populations with near perfect accuracy using a detection technique devised by research teams led by Robert Wieder, MD, PhD, at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School and Rajan Kumar, MD, PhD, at Genome Data Systems in Hamilton, N.J. This technique may facilitate cancer diagnosis, which often relies on the detection of rare cancerous cells in tiny amounts of biopsy tissue or fluid.

Pericardial window operation not effective in lung cancer cases, say researchers

Pericardial window operation, a procedure, where abnormal quantity of malignant fluid, or malignant pericardial effusion (MPE), surrounding the heart, is drained into the neighbouring chest cavity through a surgically placed tube, is commonly applied to patients diagnosed with cancer.

Ventana now offers FDA-cleared image analysis and digital read application for IHC breast markers

Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration for the Companion Algorithm ER (SP1) image analysis algorithm used with the VENTANA iScan Coreo scanner running Virtuoso software. With this clearance, Ventana is now the only company in the industry offering a comprehensive portfolio of FDA-cleared image analysis algorithms and digital read applications for the five key immunohistochemistry breast markers.

Researchers report development of multi-parameter sorting approach to part SSCs from cancerous cells

As success rates in treating childhood cancers have improved, greater emphasis is being placed on quality of life issues following successful treatment.

First analyses on impact of Medicare Part D presented at UMB's 2010 Academy/Health Annual Meeting

Some of the first analyses on the impact of Medicare Part D, as well as new insights on drug adherence patterns by chronic disease patients, will be presented today and tomorrow at the 2010 Academy/Health Annual Meeting by several University of Maryland, Baltimore teams of pharmaceutical health services researchers.

Earl Jefferson, - Counselor in Vallejo, CA